rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
52
|
pubmed:dateCreated |
2001-12-25
|
pubmed:databankReference |
|
pubmed:abstractText |
Human ovarian cancer cells and tissues were examined for the presence or absence of a 42-bp splicing variant of ERCC1 gene, and for a possible functional role of this 42-bp sequence. This specific sequence exists in exon I, the 5'-UTR of the gene. Loss of this 42-bp sequence was associated with increased ERCC1 mRNA expression, in an assessment of 121 ovarian cancer specimens (p2<10(-6)). In cells in tissue culture, the absence of the 42-bp segment was associated with a twofold increased ability to drive transcription in a Luciferase reporter system. Protein can be demonstrated in ovarian cancer cells based on EMSA analysis. Computer analysis shows that this 42-bp sequence contains several binding sites, including a core-binding domain for protein RFX1, transcriptional repressor. These preliminary results lay the groundwork in determination of potential roles for a negative regulatory element in NER repair pathway.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/5' Untranslated Regions,
http://linkedlifedata.com/resource/pubmed/chemical/DNA-Binding Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/ERCC1 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Endonucleases,
http://linkedlifedata.com/resource/pubmed/chemical/Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger,
http://linkedlifedata.com/resource/pubmed/chemical/Repressor Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Transcription Factors,
http://linkedlifedata.com/resource/pubmed/chemical/regulatory factor X transcription...
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0950-9232
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
20
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
7694-8
|
pubmed:dateRevised |
2008-9-5
|
pubmed:meshHeading |
pubmed-meshheading:11753647-5' Untranslated Regions,
pubmed-meshheading:11753647-Alternative Splicing,
pubmed-meshheading:11753647-Base Sequence,
pubmed-meshheading:11753647-DNA Repair,
pubmed-meshheading:11753647-DNA-Binding Proteins,
pubmed-meshheading:11753647-Endonucleases,
pubmed-meshheading:11753647-Exons,
pubmed-meshheading:11753647-Female,
pubmed-meshheading:11753647-Humans,
pubmed-meshheading:11753647-Molecular Sequence Data,
pubmed-meshheading:11753647-Ovarian Neoplasms,
pubmed-meshheading:11753647-Proteins,
pubmed-meshheading:11753647-RNA, Messenger,
pubmed-meshheading:11753647-Repressor Proteins,
pubmed-meshheading:11753647-Transcription, Genetic,
pubmed-meshheading:11753647-Transcription Factors,
pubmed-meshheading:11753647-Tumor Cells, Cultured
|
pubmed:year |
2001
|
pubmed:articleTitle |
An ERCC1 splicing variant involving the 5'-UTR of the mRNA may have a transcriptional modulatory function.
|
pubmed:affiliation |
West Virginia University, Mary Babb Randolph Cancer Center, Robert C. Byrd Health Sciences Center, 1801 Health Sciences South, P.O. Box 9300, Morgantown, WV 26506-9300, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|